Added to YB: 2025-02-05
Pitch date: 2025-02-04
DERM [bullish]
Journey Medical Corporation
+39.93%
current return
Author Info
The 10x Radar shares high-conviction small and microcap stock pitches with the potential to deliver multi-bagger returns. Sign up for the newsletter.
Company Info
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
Market Cap
$177.0M
Pitch Price
$5.36
Price Target
15.00 (+120%)
Dividend
N/A
EV/EBITDA
119.72
P/E
-28.15
EV/Sales
2.60
Sector
Pharmaceuticals
Category
growth
Journey Medical: A Small-Cap Multibagger Hiding in Plain Sight
DERM: FDA-approved Emrosi for rosacea, launching 2025. Potential to capture 25-30% of $300M Oracea market by 2027. Profitable base biz, $55M rev. Strong sales team, 80% coverage. Risks: generic competition, launch execution. $4.50/share, 3-4x upside potential to $15 by 2027.
Read full article (5 min)